This book is a concise, practical guide to prostate pathology and is structured to guide pathologists, both practicing and trainees, in the diagnostic process. Numerous color images and algorithms ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

BRCA mutations are inextricably linked with breasts, but they can also lead to cancer in the pancreas, the prostate, and ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically ...

Prostate cancer is the second most common cancer in men worldwide. Despite medical advances in recent years, this type of tumour is still responsible for one in eight male cancer deaths in Austria ...

Researchers determine whether artificial intelligence-based MRI data could predict prostate cancer patient outcomes.

Researchers have developed a three-dimensional mathematical model of prostate cancer. The model depicts various processes, including tumour growth, genetic evolution and tumour cell competition.

Deep Bio, a leader in artificial intelligence for digital pathology, announced a collaboration to integrate its prostate ...

Hirst III Professors of Oncology in Pathology and members of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. The scientists found that the absence of a protein called PKCλ/ι in ...

Micrograph of prostate cancer with Gleason score 6 (3+3) (photo credit: Diagnostic Pathology 11/Jennifer Gordetsky and Jonathan Epstein) The Health Ministry in Jerusalem has just published data on ...